In February 2026, Bio-Rad Laboratories reported fourth-quarter 2025 sales of US$693.2 million and net income of US$720 million, marking a return to profitability after a prior-year loss, alongside ...

Good day, everyone, and welcome to the Bio-Rad Fourth Quarter and Full Year 2025 Results Conference Call. At this time, I ...

Bio-Rad Laboratories (NYSE:BIO) executives said the company finished 2025 within revised guidance for revenue and operating ...

Friday, February 20, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Philip ...

Bio-Rad Laboratories Inc (BIO) reports a 3.9% sales increase in Q4 2025, driven by diagnostics growth, despite supply chain and market headwinds.

Q4 2025 Management View Jonathan DiVincenzo, President & COO, stated that Bio-Rad delivered results within revised guidance ...

PASADENA, Calif., Feb. 9, 2026 /PRNewswire/ -- Bidding opens on February 11 in a major Tiger Group biopharma-industry auction of new and late-model GMP Manufacturing and Quality Control Laboratory ...

Droplet Digital TM PCR (ddPCR TM) has been an evolving tool for precision and absolute detection in genomics for over a decade. Now, new technological innovations have created a suite of options that ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

Electric bike company Rad Power Bikes has reached a deal to sell itself to a company called Life Electric Vehicles Holdings (or Life EV) for around $13.2 million, a little more than a month after ...

Bidding opens on Feb. 11 in a major Tiger Group biopharma-industry auction of new and late-model GMP Manufacturing and Quality ...